Regulation of Arf GTPase activation at the Golgi complex
高尔基复合体 Arf GTP 酶激活的调节
基本信息
- 批准号:9415454
- 负责人:
- 金额:$ 31.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:AGFG1 geneBindingBiochemicalBiochemistryBiological AssayC-terminalCell SurvivalCellsCellular MembraneCellular biologyChimera organismCollectionComplexDataDefectEukaryotic CellFeedbackFundingGeneticGoalsGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHumanIn VitroIncomeInvestigationLinkLogicMeasuresMembraneMembrane Protein TrafficModelingMolecularOrganellesOutcome StudyPathway interactionsProcessProtein SortingsProteinsRegulationRoleSNAP receptorSaccharomycetalesSignal TransductionSorting - Cell MovementVesicleYeast Model SystemYeastshuman diseasein vitro Assayin vivointermolecular interactionnovelrecruitstructural biologytemperature sensitive mutanttraffickingtrans-Golgi Networkyeast genetics
项目摘要
Project Summary/Abstract
The Golgi complex is the central sorting station for nearly a third of all proteins in eukaryotic cells, but
how cells regulate the complex flow of material through this organelle remains largely unknown. Protein and
membrane traffic at the Golgi is controlled by Arf GTPases that function by recruiting effectors to make
outgoing vesicles and tether incoming vesicles. The master regulators that activate Arf GTPase pathways are
Arf-GEFs (guanine nucleotide exchange factors). In order to understand the molecular logic of Golgi
trafficking, we must understand how the Golgi Arf-GEFs are regulated to make the molecular decision of
where and when to activate their substrate Arf proteins. We have uncovered regulatory mechanisms that
govern the function of the trans-Golgi network (TGN)-localized Arf-GEF, Sec7. We discovered that Sec7 can
switch between autoinhibited and activated states, and is regulated by direct interactions with the activated
forms of four different Golgi GTPases: Ypt31/32 (Rab11), Ypt1 (Rab1), Arl1, and Arf1. This collection of
interactions represents a previously unappreciated level of crosstalk between these prominent Golgi GTPase
pathways. Key questions remain regarding the biochemical basis for Sec7 regulation and the cell biology
underpinning these interactions. Furthermore, we have determined that Gea1 and Gea2, the Arf-GEFs that
localize to early Golgi compartments, are regulated through mechanisms that are distinct from those of Sec7.
Our long-term goal is to determine how cells regulate trafficking at the Golgi complex. In order to both
broaden and deepen our mechanistic understanding of the regulation of Arf activation at the Golgi, we
propose the following Aims for this project: 1) Investigate the intra-molecular and inter-molecular
interactions that regulate Sec7. We will use our established in vitro assays to characterize a newly identified
functional link between distinct Sec7 regulatory domains. Using a new assay for measuring Sec7 activity in
vivo, we will explore the possibilities that Sec7 integrates multiple GTPase signals and can sense and respond
to changes in Golgi cargo load. We will perform an intragenic suppressor screen to identify new functional
connections between Sec7 regulatory domains. Finally, we will seek additional structural information
regarding the Sec7 C-terminal regulatory domains. 2) Determine the mechanisms regulating localization and
activity of the early-Golgi Arf-GEFs Gea1/2. In order to understand how trafficking is regulated at the early-
Golgi, we will perform a comprehensive investigation of the mechanisms regulating Gea1/2 membrane
localization and activity. We will utilize chimeras and temperature sensitive-mutants to identify and
characterize the regions of Gea1/2 regulating localization and activity. We will combine in vitro and in vivo
approaches to characterize the roles of Gea1/2 binding partners. Finally, we will seek structural information to
explain the basis for Gea1/2 regulation. We expect the outcome of these studies will be new and refined
mechanistic models for regulation of trafficking at the Golgi complex.
项目概要/摘要
高尔基复合体是真核细胞中近三分之一蛋白质的中央分选站,但是
细胞如何调节通过该细胞器的复杂物质流仍然很大程度上未知。蛋白质和
高尔基体的膜交通由 Arf GTPases 控制,Arf GTPases 通过招募效应器来发挥作用
输出囊泡和束缚传入囊泡。激活 Arf GTPase 途径的主要调节因子是
Arf-GEF(鸟嘌呤核苷酸交换因子)。为了理解高尔基体的分子逻辑
贩运,我们必须了解高尔基体 Arf-GEF 是如何调节的,以做出分子决定
何时何地激活其底物 Arf 蛋白。我们已经发现了监管机制
管理跨高尔基体网络(TGN)定位的 Arf-GEF,Sec7 的功能。我们发现 Sec7 可以
在自动抑制和激活状态之间切换,并通过与激活状态的直接相互作用来调节
四种不同高尔基体 GTP 酶的形式:Ypt31/32 (Rab11)、Ypt1 (Rab1)、Arl1 和 Arf1。这本合集
相互作用代表了这些突出的高尔基体 GTP 酶之间以前未被认识到的串扰水平
途径。关于 Sec7 调节的生化基础和细胞生物学的关键问题仍然存在
支撑这些相互作用。此外,我们还确定了 Gea1 和 Gea2,即 Arf-GEF
定位于早期高尔基体区室,通过与 Sec7 不同的机制进行调节。
我们的长期目标是确定细胞如何调节高尔基复合体的运输。为了两者
为了扩大和加深我们对高尔基体 Arf 激活调节机制的理解,我们
为该项目提出以下目标: 1)研究分子内和分子间
调节 Sec7 的相互作用。我们将使用我们已建立的体外测定来表征新鉴定的
不同 Sec7 监管域之间的功能联系。使用新的检测方法测量 Sec7 活性
vivo,我们将探索Sec7整合多个GTPase信号并能够感知和响应的可能性
高尔基体货物负载的变化。我们将进行基因内抑制子筛选,以确定新的功能
Sec7 监管域之间的连接。最后,我们将寻求额外的结构信息
关于 Sec7 C 末端监管域。 2) 确定本地化调控机制
早期高尔基体 Arf-GEF Gea1/2 的活性。为了尽早了解贩运活动是如何受到监管的
高尔基体,我们将对Gea1/2膜的调节机制进行全面的研究
本地化和活动。我们将利用嵌合体和温度敏感突变体来识别和
描述 Gea1/2 调节定位和活动的区域。我们将体外和体内结合起来
表征 Gea1/2 结合伴侣作用的方法。最后,我们将寻求结构信息
解释 Gea1/2 调节的基础。我们预计这些研究的结果将会是新的和完善的
高尔基复合体贩运调节的机械模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J Christopher Fromme其他文献
J Christopher Fromme的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J Christopher Fromme', 18)}}的其他基金
GTPase Regulation of the Golgi Complex (Diversity Supplement 2023)
高尔基复合体的 GTPase 调节(多样性补充资料 2023)
- 批准号:
10800329 - 财政年份:2020
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Rab activation at the Golgi complex
高尔基复合体 Rab 激活的调节
- 批准号:
9005350 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Rab activation at the Golgi complex
高尔基复合体 Rab 激活的调节
- 批准号:
9197321 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
8245998 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the Golgi complex
高尔基复合体 Arf GTP 酶激活的调节
- 批准号:
9234934 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
8413049 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
Regulation of Arf GTPase activation at the trans-Golgi network
跨高尔基体网络 Arf GTPase 激活的调节
- 批准号:
9000156 - 财政年份:2012
- 资助金额:
$ 31.1万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
髓系恶性肿瘤中致癌 NRAS 信号传导的新调控
- 批准号:
10467363 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
髓系恶性肿瘤中致癌 NRAS 信号传导的新调控
- 批准号:
10580053 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Elucidating the Complexin C-terminal Domain Mechanism in Neurotransmission Regulation
阐明神经传递调节中的复合蛋白 C 末端结构域机制
- 批准号:
10624237 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Dysregulation of iron homeostasis by mutant LRRK2 in human neurons
人类神经元中突变型 LRRK2 导致铁稳态失调
- 批准号:
10592478 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别: